Ciphergen Stock Jumps 6.8 Percent on Positive Nasdaq Outcome

Aug 25, 2006

NEW YORK (GenomeWeb News) – Shares in Ciphergen Biosystems were up 6.76 percent, or $.09, at $1.42 in mid-afternoon trading after the company said its shares have regained compliance with the Nasdaq exchange.

As GenomeWeb News reported this morning, Ciphergen said the exchange has allowed it to move its shares to its Capital Market from the National Market.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Now You Can Read Them, Now You Can't

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

The Mouths of Heavy Drinkers Are Disgusting

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

For Health or For Fun?

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

This Week in Genome Research

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.

Main menu